Assessing the potential of hypochlorous acid-oxidised allogeneic tumour cells as a source of antigens for dendritic cell-based immunotherapy of ovarian carcinoma and melanoma

by Cheryl, Lai Lai Chiang
Published 2009

Whole Tumor Antigen Vaccines: Where Are We?

by Cheryl Lai-Lai Chiang, George Coukos, Lana E. Kandalaft
Published 2015-04-01

Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human

by Cheryl Lai-Lai Chiang, Raphaël Rovelli, Apostolos Sarivalasis, Lana E. Kandalaft
Published 2021-09-01

Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

by Silvia Martin Lluesma, Michele Graciotti, Cheryl Lai-Lai Chiang, Lana E. Kandalaft
Published 2018-11-01

Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors

by Chakradhar Yakkala, Cheryl Lai-Lai Chiang, Lana Kandalaft, Lana Kandalaft, Alban Denys, Rafael Duran
Published 2019-09-01

Rate of Freeze Impacts the Survival and Immune Responses Post Cryoablation of Melanoma

by Chakradhar Yakkala, Julien Dagher, Christine Sempoux, Cheryl Lai-Lai Chiang, Alban Denys, Lana E. Kandalaft, Lana E. Kandalaft, Bhanu Koppolu, Rafael Duran
Published 2021-06-01

Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.

by Cheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, Rosemarie Mick, Thomas Garrabrant, Brian J Czerniecki, Lana E Kandalaft, Daniel J Powell, George Coukos
Published 2011-01-01